🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.

RecruitingNAAges 18 Years - anyAllAssistance Publique - Hôpitaux de Paris
NCT05095714 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Intro: Hepatocellular carcinoma (HCC) is the 6th leading cause of cancer worldwide. In France, more than 10,000 new cases are identified each year. The latter occur in 85% of cases in cirrhosis, the most frequent causes of which are excessive alcohol consumption, metabolic syndrome or HBV/HCV infection. Patients with cirrhosis justify being included in monitoring programs involving the performance of a semi-annual liver ultrasound (US) in order to detect HCC eligible for curative treatment (liver resection or percutaneous ablation). This practice is considered to be cost-effective in the event of an annual incidence of HCC\> 1.5%. US in this context has a low sensitivity for the detection of HCC at the very early stage and the following observations have been made in the last 20 years: * The rate of patients detected at early stage BCLC 0 is around 30% by ultrasound * The rate of patien

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * Patient enrolled in a screening program for at least 6 months in a tertiary hepatology center * Cirrhosis histologically proven or unequivocally suggested by non-invasive tests * Absence of HCC on imaging less than 3 months o * Liver parenchyma explorable by ultrasound * Child-Pugh A or B * Cirrhosis of non-viral or viral B/C cause controlled/healed * With an estimated annual risk of HCC\>3% * Written informed consent * Affiliation to a social security system Exclusion Criteria: * Child-Pugh C score * Active hepatitis B or C * Estimated annual risk of HCC\<3% * No prior enrollment in a screening program * Contraindication to Fast-MRI * Non-echogenic patient * Patient deprived of liberty * Patient under legal protection * Pregnant or breastfeeding woman * Patient on AME (state medical aid)
💊

What it tests

  • Liver ultrasound and fast-MRI
  • Liver ultrasound
📍

Where

1 site
Assistance Publique Hôpitaux de Paris - Hôpital Avicenne
Bondy, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy